560 related articles for article (PubMed ID: 23548338)
1. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis.
Deo SV; Shah IK; Dunlay SM; Erwin PJ; Dillon JM; Park SJ
Heart Lung Circ; 2013 Oct; 22(10):827-35. PubMed ID: 23548338
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
[TBL] [Abstract][Full Text] [Related]
4. Drug-Eluting Stents Versus Coronary Artery Bypass Grafts for Left Main Coronary Disease: A Meta-Analysis and Review of Randomised Controlled Trials.
Moore P; Burrage M; Garrahy P; Lim R; McCann A; Camuglia A
Heart Lung Circ; 2018 Dec; 27(12):1437-1445. PubMed ID: 29102437
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
[TBL] [Abstract][Full Text] [Related]
6. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
Raja SG; Benedetto U; Ilsley CD; Amrani M;
Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
[TBL] [Abstract][Full Text] [Related]
8. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.
Verma S; Farkouh ME; Yanagawa B; Fitchett DH; Ahsan MR; Ruel M; Sud S; Gupta M; Singh S; Gupta N; Cheema AN; Leiter LA; Fedak PW; Teoh H; Latter DA; Fuster V; Friedrich JO
Lancet Diabetes Endocrinol; 2013 Dec; 1(4):317-28. PubMed ID: 24622417
[TBL] [Abstract][Full Text] [Related]
9. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis.
Ariyaratne TV; Ademi Z; Yap CH; Billah B; Rosenfeldt F; Yan BP; Reid CM
Int J Cardiol; 2014 Sep; 176(2):346-53. PubMed ID: 25127976
[TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Isolated Proximal Left Anterior Descending Coronary Disease.
Kinnaird T; Kwok CS; Narain A; Butler R; Ossei-Gerning N; Ludman P; Moat N; Anderson R; Mamas MA
Am J Cardiol; 2016 Oct; 118(8):1171-1177. PubMed ID: 27553097
[TBL] [Abstract][Full Text] [Related]
11. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
12. Comparison of coronary artery bypass graft versus drug-eluting stents in dialysis patients: an updated systemic review and meta-analysis.
Prasitlumkum N; Cheungpasitporn W; Sato R; Thangjui S; Thongprayoon C; Kewcharoen J; Bathini T; Vallabhajosyula S; Ratanapo S; Chokesuwattanaskul R
J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):285-296. PubMed ID: 33633044
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stent placement versus coronary artery bypass surgery for unprotected left main coronary artery disease: A meta-analysis of randomized controlled trials.
Upadhaya S; Baniya R; Madala S; Subedi SK; Khan J; Velagapudi RK; Bachuwa G
J Card Surg; 2017 Feb; 32(2):70-79. PubMed ID: 28081585
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Systolic Dysfunction.
Cui K; Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M
Am J Cardiol; 2018 Nov; 122(10):1670-1676. PubMed ID: 30220418
[TBL] [Abstract][Full Text] [Related]
16. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.
Huang F; Lai W; Chan C; Peng H; Zhang F; Zhou Y; Teng S; Huang Z
Cardiol J; 2015; 22(2):123-34. PubMed ID: 24846507
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery bypass grafting versus drug-eluting stents in patients with end-stage renal disease.
Deo SV; Shah IK; Dunlay SM; Lim JY; Erwin PJ; Dillon JJ; Park SJ
J Card Surg; 2014 Mar; 29(2):163-9. PubMed ID: 24447133
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
20. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
